Novo Nordisk Named 'Best Place to Work in New Jersey'
Posted on: Thursday, 30 April 2009, 07:00 CDT
Renowned employer of choice takes top spot for third time; second award in 2009
"This award is a tribute to our unique company culture and our commitment to inspire and engage our employees through our company's vision of defeating diabetes," said
The ranking is based on an independent assessment of policies, practices and demographics as well as a comprehensive employee survey.
"Our continued presence and high ranking on the list demonstrates the value we place on the personal and professional satisfaction and growth of our employees," said
Among the company attributes considered in Novo Nordisk's recognition is the company's creative benefits program for employees in a variety of areas. This year, Novo Nordisk developed and implemented College Coach, a program that assists parents with preparing for college savings. Other company efforts include concierge services, backup care for children and dependent adults, and a generous 401k plan: Novo Nordisk contributes 8 percent to an employee's 401k even if that individual does not participate.
In addition to finding professional gratification, Novo Nordisk employees report an emotional connection with the company's goals. In the most recent annual survey employees rated an average score of 4.68 out of a possible five to indicate their level of agreement with statements including "Novo Nordisk is leading the fight against diabetes," "Novo Nordisk's results within the social and environmental area are important to the future of the company," and "I am proud of our products."
The "Best Place to Work in New Jersey" award is part of the weekly publication's annual survey to honor the companies in
About Novo Nordisk
Novo Nordisk is a healthcare company with an 86-year history of innovation and achievement in diabetes care. The company has the broadest diabetes product portfolio in the industry, including the most advanced products within the area of insulin delivery systems. In addition to diabetes care, Novo Nordisk has a leading position within areas such as hemostasis management, growth hormone therapy, and hormone therapy for women. Novo Nordisk's business is driven by the Triple Bottom Line: a commitment to social responsibility to employees and customers, environmental soundness and economic success. With headquarters in
SOURCE Novo Nordisk
Source: PR Newswire
Related Articles
- Shire Continues to Deliver Excellent Growth From Core Products
- Partnership for Peak Healthcare Performance Provides First Reports to Doctors on Level of Diabetes Care
- Nick Jonas and Bayer Diabetes Care Launch Creativity Contest to Encourage Kids With Diabetes to Express Their Simple Win
- NationsHealth Acquires Diabetes Care & Education, Inc.
- The International Diabetes Federation Launches US$ 10 Million Grant Programme to Improve Diabetes Care
- Drug Cos. Set Sights on Diabetes Care
- Depomed Data Published in Diabetes Care on Glumetza, an FDA-Approved Treatment for Type II Diabetes
- Hitachi Data Systems Wins VARBusiness ARC Award for Best Product Innovation in Network Storage
- Newt Gingrich and Novo Nordisk Join Texas Health Care Leaders in a Call-to-Action Against the Diabetes Epidemic
- Health Care Spending Growth Slows Considerably
User Comments (0)

RSS Feeds